-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Verastem, Raises Price Target to $20

Benzinga·11/06/2026 12:03:19
Listen to the news
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Verastem (NASDAQ:VSTM) with a Buy and raises the price target from $18 to $20.